Tradestie Institutional Equity Comparison Engine
SYK vs BDX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BDX Overall Edge
BDX Captures Institutional Edge (3โ1 Pillars ยท 3โ7 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Becton, Dickinson and Co. (BDX) driven by superior Valuation, Momentum & Technical, Options & Structure while SYK counters with relative strength in Growth & Margin. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus BDX at 16.4x Forward P/E and 15.7% operating margin (-10.5% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against BDX sits in BREAKOUT (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BDX
SYK 19.0x vs BDX 16.4x Fwd P/E
Growth & Margin Winner
SYK
Op Margin 24.0% vs 15.7% ยท YoY +7.6% vs -10.5%
Momentum & Technical Winner
BDX
1Y -16.8% vs +12.2% ยท 52W Pos 36% vs 95%
Options & Structure Winner
BDX
SURGE (5th %ile IV) vs BREAKOUT (7th %ile IV)
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
BDX
NYSE
Becton, Dickinson and Co.
Surgical & Medical Instruments & Apparatus
$216.52
-0.69% 1D
Market Cap
$58.8B
1M Return
+12.92%
1Y Return
+12.16%
Forward P/E
16.4x
Unified AI Score
33.7 / 100
SELL
Tech 5.0
Fund 34.0
Flow 65.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SYK -16.77%
BDX +12.16%
Spread: +28.93 pp (BDX Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SYK Revenue | BDX Revenue | SYK Op. Margin | BDX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $13.6B | $16.0B | 18.7% | 9.4% | SYK |
| FY2019 | $14.9B | $17.3B | 18.2% | 10.2% | SYK |
| FY2020 | $14.3B | $16.1B | 15.5% | 5.7% | SYK |
| FY2021 | $17.1B | $19.1B | 15.1% | 11.8% | SYK |
| FY2022 | $18.4B | $18.9B | 15.4% | 12.1% | SYK |
| FY2023 | $20.5B | $19.4B | 19.0% | 10.9% | SYK |
| FY2024 | $22.6B | $20.2B | 16.3% | 11.9% | SYK |
| FY2025 | $25.1B | $21.8B | 19.5% | 11.8% | SYK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SYK | BDX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $118.9B | $58.8B | Larger Scale | SYK |
| Trailing P/E Ratio Valuation | 33.3x | 42.6x | Lower Multiple | SYK |
| Forward P/E Ratio Valuation | 19.0x | 16.4x | Lower Multiple | BDX |
| Revenue Growth (YoY) Growth | +7.6% | -10.5% | Higher Growth | SYK |
| Operating Margin (TTM) Profitability | 24.0% | 15.7% | Higher Margin | SYK |
| Net Profit Margin Profitability | 13.8% | 5.9% | Higher Margin | SYK |
| Return on Equity (ROE) Capital Efficiency | 16.0% | 5.7% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 36% ($267โ$389) | 95% ($140โ$220) | Stronger Trend | BDX |
| Beta / 30D Volatility Risk Regime | 0.22ฮฒ ยท 50% Vol | 0.16ฮฒ ยท 25% Vol | Lower Realized Risk | BDX |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 33.7 / 100 (SELL) | Higher Composite | SYK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SYK vs BDX Buy Guide
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
BDX
BREAKOUT
60d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SYK nor BDX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.